BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 118 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $141,600 | +0.6% | 20,000 | 0.0% | 0.12% | +14.2% |
| Q2 2023 | $140,800 | +84211.4% | 20,000 | 0.0% | 0.11% | -19.1% |
| Q1 2023 | $167 | -27.4% | 20,000 | 0.0% | 0.13% | -19.1% |
| Q4 2022 | $230 | -99.9% | 20,000 | 0.0% | 0.16% | -8.5% |
| Q3 2022 | $252,000 | +18.9% | 20,000 | 0.0% | 0.18% | +14.9% |
| Q2 2022 | $212,000 | -34.8% | 20,000 | 0.0% | 0.15% | -34.2% |
| Q1 2022 | $325,000 | +17.3% | 20,000 | 0.0% | 0.23% | +30.7% |
| Q4 2021 | $277,000 | -3.5% | 20,000 | 0.0% | 0.18% | -8.2% |
| Q3 2021 | $287,000 | -9.2% | 20,000 | 0.0% | 0.20% | +3.2% |
| Q2 2021 | $316,000 | +55.7% | 20,000 | 0.0% | 0.19% | +56.2% |
| Q1 2021 | $203,000 | +36.2% | 20,000 | 0.0% | 0.12% | +40.7% |
| Q4 2020 | $149,000 | +8.0% | 20,000 | -50.0% | 0.09% | +87.0% |
| Q3 2020 | $138,000 | +45.3% | 40,000 | +100.0% | 0.05% | -19.3% |
| Q2 2020 | $95,000 | +137.5% | 20,000 | 0.0% | 0.06% | +62.9% |
| Q1 2020 | $40,000 | -42.0% | 20,000 | 0.0% | 0.04% | -30.0% |
| Q4 2019 | $69,000 | +21.1% | 20,000 | 0.0% | 0.05% | +31.6% |
| Q3 2019 | $57,000 | -25.0% | 20,000 | 0.0% | 0.04% | -17.4% |
| Q2 2019 | $76,000 | – | 20,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $38,430,000 | 18.43% |
| RTW INVESTMENTS, LP | 4,078,895 | $25,819,000 | 9.72% |
| VHCP Management, LLC | 1,155,104 | $7,312,000 | 7.86% |
| RA Capital Management | 2,989,795 | $18,925,000 | 2.68% |
| DLD Asset Management, LP | 1,258,700 | $7,967,000 | 2.61% |
| Avoro Capital Advisors LLC | 1,631,502 | $10,327,000 | 2.09% |
| Ghost Tree Capital, LLC | 1,150,000 | $7,280,000 | 1.75% |
| GREAT POINT PARTNERS LLC | 725,000 | $4,589,000 | 0.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,237,734 | $20,495,000 | 0.84% |
| Baker Brothers Advisors | 10,963,944 | $69,402,000 | 0.68% |